THE KEYSTONE ADVANTAGE FOR PHARMA

The pharmaceutical industry has the untapped power — the kinetic potential — to change the nature of economic competition. But to get there, it will need to construct new market power.

The future won't happen by tweaking the edges of 'drug market' boundaries, using artificial intelligence to automate legacy operating models, or engaging in a discursive war with governments over “drug pricing.”

It's invented, in an organized way, with new system vision, one that enables a number of different markets to collaborate, cohere and compete on outcomes delivered through new economic systems ('ecosystem value').

A new strategy story starts here.